Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Electrical Brain Stimulation for College Students With Short-Form Video Addiction: Effects and Mechanisms

6 de noviembre de 2026 actualizado por: Beijing Normal University

Effects and Mechanisms of High-Definition Transcranial Direct Current Stimulation (HD-tDCS) Intervention on Short-Form Video Addiction

The researchers will test whether high-definition transcranial direct current stimulation (HD-tDCS) combined with real-time short-form video cue exposure can reduce addiction severity and daily usage time in college students with problematic short-form video use. By modulating the dorsolateral prefrontal cortex, this study aims to explore whether the treatment improves executive function (such as self-control and risk decision-making) and emotional-cognitive processes (such as craving and attentional bias). Assessments will be conducted before, immediately after the 2-week intervention, and at a 4-week follow-up, using both subjective surveys and objective computer cognitive tasks. Results could pave the way for a low-cost, non-invasive, and scalable intervention strategy to address the growing public health concern of short-form video addiction among young adults.

Descripción general del estudio

Descripción detallada

Over the past few years, problematic short-form video use has emerged as a significant public health concern among college students, associated with impaired executive function, academic decline, and emotional distress. Neuroimaging studies suggest that excessive short-form video consumption is linked to hypoactivity in the dorsolateral prefrontal cortex (dlPFC), which disrupts the balance between cognitive control and reward-driven habits. However, evidence-based non-pharmacological interventions for short-form video addiction remain scarce.

This study builds upon the dual-pathway model of internet addiction and utilizes a high-definition tDCS (HD-tDCS) protocol with a 4x1 ring configuration targeting the right dlPFC (center anode with 4 surrounding return electrodes) to restore prefrontal control. Participants will receive 10 daily HD-tDCS sessions over 2 consecutive weeks. Crucially, to enhance the targeted therapeutic effect, participants will undergo concurrent cue exposure-watching short-form videos on their personal mobile phones for 12 minutes during each 15-minute active or sham HD-tDCS session.

This randomized, double-blind, sham-controlled trial (N=82) employs a longitudinal design with three assessment time points (baseline, post-intervention at week 2, and a 4-week follow-up). We hypothesize that active HD-tDCS will significantly reduce addiction symptoms and usage duration compared to sham. Furthermore, we propose a parallel mediation model to explore the underlying mechanisms: specifically, whether the intervention effect is mediated by improvements in executive function (response inhibition and risk decision-making) and emotional-cognitive pathways (reductions in craving and attentional bias). Results may inform the development of scalable, neuroplasticity-based interventions to mitigate digital addiction and promote mental well-being in young adults.

The sample size was determined a priori using G*Power software (version 3.1.9.7). Based on the effect size (Cohen's f = 0.35) derived from previous meta-analytic findings regarding multiple-session tDCS interventions, assuming an alpha error probability of 0.05, a statistical power of 0.80, 2 groups, and 3 repeated measurements (i.e., pre-test, post-test, and 4-week follow-up), a minimum total sample size of 82 participants is required.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

82

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Ubicaciones de estudio

    • Beijing Municipality
      • Beijing, Beijing Municipality, Porcelana, 100088
        • Department of Psychology, Beijing Normal University
        • Contacto:

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 30 años (Adulto)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Age between 18 and 30 years.
  • Currently enrolled as a university student.
  • Right-handed.
  • Meets the threshold for problematic short-form video use, as assessed by the Short-form Video Addiction Scale.
  • Primary use: The participant's primary problematic internet use is short-form videos, rather than other behaviors such as online gaming.

Exclusion Criteria:

  • Diagnosed psychiatric disorders.
  • History of neurological disease or traumatic brain injury.
  • History of epilepsy or a family history of epilepsy.
  • Presence of medical implants (e.g., cardiac pacemakers, cochlear implants).
  • Currently receiving pharmacological or psychological treatment.
  • History of receiving any non-invasive brain stimulation (e.g., tDCS, TMS, or tACS) within the past year.
  • Any other contraindications to HD-tDCS (e.g., history of skin lesions/scalp conditions at the electrode sites) or severe physical diseases identified during safety screening.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Doble

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Active HD-tDCS Group

Participants receive active high-definition transcranial direct current stimulation (HD-tDCS) using a NeuroConn stimulator. A 4x1 ring electrode configuration is applied: the center anodal (positive) electrode is placed over the right dorsolateral prefrontal cortex (F4), surrounded by four cathodal (negative) return electrodes. The stimulation is delivered at 1.5 mA for 15 minutes. Participants receive one session per day, 5 days per week, for 2 consecutive weeks.

Description: Active HD-tDCS is delivered using a NeuroConn device with a 4x1 ring configuration (center anodal electrode over the right dlPFC, surrounded by 4 cathodal returns). The stimulation is delivered at 1.5 mA for 15 minutes. Participants receive 10 sessions over 2 consecutive weeks (5 days/week). Concurrently during the stimulation, participants watch short-form videos on their mobile phones for approximately 14-15 minutes (using the same platform identified at baseline). A pre-programmed active code ensures strict double-blinding.

Comparador falso: Sham HD-tDCS Group

Participants receive sham HD-tDCS using the identical NeuroConn device, 4x1 ring electrode configuration, and procedure as the active group. The device delivers a brief current (ramped up and down over 30 seconds) at the beginning of the 15-minute session to mimic the initial skin sensation, but the current is turned off for the remainder of the session. Participants receive one session per day, 5 days per week, for 2 consecutive weeks.

Description: Sham HD-tDCS uses the identical NeuroConn device and 4x1 ring configuration as the active group. The current is ramped up for 30 seconds and then turned off for the remainder of the 15-minute session to mimic the initial skin sensation. Participants receive 10 sessions over 2 consecutive weeks (5 days/week). Concurrently during the sham stimulation, participants watch short-form videos on their mobile phones for approximately 14-15 minutes (using the same platform identified at baseline). A pre-programmed sham code ensures strict double-blinding.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Short-form Video Addiction Scale Score
Periodo de tiempo: Baseline (Pre-test), Week 2 (Post-test), and Follow-up at 4 weeks after the intervention

Assessed using the 25-item Short-form Video Addiction Scale, which includes two dimensions: Addictive Dependence and Negative Consequence. Each item is scored on a 7-point Likert scale (1 = strongly disagree, 7 = strongly agree). The total score ranges from 25 to 175. A higher score indicates a more severe level of short-form video addiction.

Baseline (Pre-test), Week 2 (Post-test), and Follow-up at 4 weeks after the intervention
Change in Average Daily Short-form Video Use Duration
Periodo de tiempo: Baseline (Pre-test), Week 2 (Post-test), and Follow-up at 4 weeks after the intervention

Self-reported average time (in minutes) spent watching short-form videos per day over the past week. A higher duration indicates more excessive use.

Baseline (Pre-test), Week 2 (Post-test), and Follow-up at 4 weeks after the intervention

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Executive Function Composite Score (SSRT & BART)
Periodo de tiempo: Baseline (Pre-test), Week 2 (Post-test), and Follow-up at 4 weeks after the intervention

A composite executive function score will be derived using Exploratory Factor Analysis (EFA) from two tasks: (1) Stop-Signal Reaction Time (SSRT) from the Stop-Signal Task, and (2) Adjusted Average Pumps (AAP) from the Balloon Analogue Risk Task (BART). The factor score extracted from the EFA will serve as the composite indicator, accounting for the relative weighting of each measure. Factor scores will be oriented such that higher values indicate better overall executive function.

Baseline (Pre-test), Week 2 (Post-test), and Follow-up at 4 weeks after the intervention
Change in Emotion-Cognition Composite Score (Craving, ABS, ER)
Periodo de tiempo: Baseline (Pre-test), Week 2 (Post-test), and Follow-up at 4 weeks after the intervention

A composite emotion-cognition score will be derived using Exploratory Factor Analysis (EFA) from three measures: (1) Craving Score, (2) Attentional Bias Score (ABS) from the dot-probe task, and (3) Emotion Regulation Score. The factor score extracted from the EFA will serve as the composite indicator to capture the shared variance among these measures. Factor scores will be oriented such that higher values indicate more favorable emotional-cognitive outcomes.

Baseline (Pre-test), Week 2 (Post-test), and Follow-up at 4 weeks after the intervention

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

15 de noviembre de 2026

Finalización primaria (Estimado)

31 de mayo de 2027

Finalización del estudio (Estimado)

30 de junio de 2027

Fechas de registro del estudio

Enviado por primera vez

6 de noviembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

6 de noviembre de 2026

Publicado por primera vez (Actual)

12 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

12 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

6 de noviembre de 2026

Última verificación

1 de octubre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir